Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.55 SEK | -2.47% | +10.73% | +76.95% |
Sales 2024 * | 63.6M 6.02M | Sales 2025 * | 1.2B 114M | Capitalization | 2.21B 209M |
---|---|---|---|---|---|
Net income 2024 * | -417M -39.45M | Net income 2025 * | 511M 48.34M | EV / Sales 2024 * | 21.1 x |
Net cash position 2024 * | 866M 81.92M | Net cash position 2025 * | 1.49B 141M | EV / Sales 2025 * | 0.59 x |
P/E ratio 2024 * |
-8.54
x | P/E ratio 2025 * |
3.45
x | Employees | 109 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on BioInvent International AB
1 day | -2.47% | ||
1 week | +13.54% | ||
Current month | +29.04% | ||
1 month | +33.40% | ||
3 months | +106.84% | ||
6 months | +120.14% | ||
Current year | +76.95% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Welschof
CEO | Chief Executive Officer | 63 | 18-08-31 |
Stefan Ericsson
DFI | Director of Finance/CFO | 61 | 97-12-31 |
Marie Moores
COO | Chief Operating Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 17-12-31 |
Leonard Kruimer
CHM | Chairman | 66 | 16-05-11 |
Vincent Ossipow
BRD | Director/Board Member | 55 | 16-05-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 33.55 | -2.47% | 135,421 |
24-05-27 | 34.4 | +4.40% | 190,250 |
24-05-24 | 32.95 | +3.62% | 189,315 |
24-05-23 | 31.8 | +6.00% | 228,714 |
24-05-22 | 30 | -0.99% | 181,035 |
Delayed Quote Nasdaq Stockholm, May 28, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.95% | 213M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- BINV Stock